Patients with multiple nodules and a dominant lung adenocarcinoma have similar outcomes and survival compared with patients who have a solitary adenocarcinoma

Interactive Cardiovascular and Thoracic Surgery

Volumn 20, Issue 2, 2015, Pages 229-235

  Castiglioni, Massimo ^a,b   Louie, Brian E ^b   Wilshire, Candice L ^b   Farivar, Alexander S ^b   Aye, Ralph W ^b   Gorden, Jed ^b   Horton, Matthew P ^c   Valli'res, Eric ^b  

^a UNIVERSITY OF INSUBRIA   (Italy)

^b SWEDISH MEDICAL CENTER   (United States)

^c Cellnetix Pathology and Laboratories   (United States)

Author keywords

Adenocarcinoma; Lung cancer surgery; Lung nodules; Multinodular; Outcomes; Uninodular

Indexed keywords

AGED; ARTICLE; CANCER GROWTH; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; DISEASE FREE SURVIVAL; DISTANT METASTASIS; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MULTIPLE PULMONARY NODULES; OVERALL SURVIVAL; RECURRENCE RISK; RETROSPECTIVE STUDY; SURVIVAL TIME; ADENOCARCINOMA; ADVERSE EFFECTS; COMPARATIVE STUDY; DISEASE COURSE; KAPLAN MEIER METHOD; LUNG NEOPLASMS; LUNG RESECTION; MIDDLE AGED; MORTALITY; PATHOLOGY; RISK FACTOR; SECONDARY; SOLITARY PULMONARY NODULE; TIME; TREATMENT OUTCOME; TUMOR RECURRENCE; VERY ELDERLY;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIPLE PULMONARY NODULES; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PNEUMONECTOMY; RETROSPECTIVE STUDIES; RISK FACTORS; SOLITARY PULMONARY NODULE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84922449043     PISSN: 15699293     EISSN: 15699285     Source Type: Journal    
DOI: 10.1093/icvts/ivu366     Document Type: Article

References (9)

1. AJCC Cancer Staging Manual, 7th Ed. Springer, Chicago, IL. Additional Notes Regarding TNM Descriptors. Page 264.
2. Gu B, Burt BM, Merritt RE, Stephanie S, NairW, Hoang CD, et al. A dominant adenocarcinoma with multifocal ground glass lesions does not behave as advanced disease. Ann Thorac Surg 2013;96:411-8.
3. Bryant AS, Cerfolio RJ. The maximum standardized uptake values on integrated FDG-PET/CT is useful in differentiating benign from malignant pulmonary nodules. Ann Thorac Surg 2006;82:1016-20.
4. Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger KR, Yatabe Y, et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society: InternationalMultidisciplinary Classification of Lung Adenocarcinoma. J Thorac Oncol 2011;6:244-85.
5. International Early Lung Cancer Action Program: enrollment and screening protocol. 2014. http://www.ielcap.org/protocols (30 March 2014, date last accessed
6. Fabian T, Bryant AS, Mouhlas AL, Federico JA, Cerfolio RJ. Survival after resection of synchronous non-small cell lung cancer. J Thorac Cardiovasc Surg 2011;142:547-53.
7. Pennathur A, Lindeman B, Ferson P, Ninan M, Quershi I, Gooding WE, et al. Surgical resection is justified in non-small cell lung cancer patients with node negative T4 satellite lesions. Ann Thorac Surg 2009;87:893-9.
8. Kim HK, Choi YS, Kim J, Shim YM, Lee KS, Kim K. Management of multiple pure ground-glass opacity lesions in patients with bronchioloalveolar carcinoma. J Thorac Oncol 2010;5:206-10.
9. Stiles BM, Schulster M, Nasar A, Paul S, Lee PC, Port JL, et al. Characteristics and outcomes of secondary nodules identified on initial computed tomography scan for primary non-small cell lung cancer. Presented at the 94th AATS Annual Meeting, 2014, Toronto, ON, Canada. General Thoracic Moderated Poster Competition